BBHC
MED icon

Brown Brothers Harriman & Co’s Medifast MED Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$63K – 1065
2018
Q4 		$63K Buy
+500
New +$85.5K ﹤0.01% 494
2018
Q1 		– Sell
-19
Closed -$1K – 996
2017
Q4 		$1K Buy
+19
New +$1.26K ﹤0.01% 1125

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Brown Brothers Harriman & Co's MED Position: Q1 2019 in Review

Brown Brothers Harriman & Co sold out of Medifast (MED) in Q1 2019, closing a stake of 500 shares — an estimated $63K sold.

Brown Brothers Harriman & Co first reported a position in MED in Q4 2017 and held it in 2 quarters. The position peaked at $63K in Q4 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • Brown Brothers Harriman & Co reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 500 Medifast shares in Q1 2019, an estimated $63K.
  • Brown Brothers Harriman & Co first reported a position in Medifast in Q4 2017 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Medifast position peaked at $63K in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2019, filed 15 May 2019.